Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare ranibizumab injection to hemodilution at the early
phase of Central Retinal Vein Occlusion (CRVO) and to determine if the combination of both
treatments may have a synergic effect.